MCMCB Pro
J0463

J0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg

HCPCSActiveBETOS O1E

J0463 is a HCPCS Level II code for injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for J0463

Long descriptor
Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg

The official wording. This is what the code means.

Short descriptor
Inj atropine (fresenius te)

CMS's 28-character form, which is what shows up on a remittance advice.

Added
April 1, 2026

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0463

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0463 is not quite right, the correct code is very often within a few positions of it.

  • J0400Injection, aripiprazole, intramuscular, 0.25 mg
  • J0401Injection, aripiprazole (abilify maintena), 1 mg
  • J0402Injection, aripiprazole (abilify asimtufii), 1 mg
  • J0456Injection, azithromycin, 500 mg
  • J0457Injection, aztreonam, 100 mg
  • J0458Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)
  • J0461Injection, atropine sulfate, 0.01 mg
  • J0462Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
  • J0470Injection, dimercaprol, per 100 mg
  • J0475Injection, baclofen, 10 mg
  • J0476Injection, baclofen, 50 mcg for intrathecal trial
  • J0480Injection, basiliximab, 20 mg
  • J0485Injection, belatacept, 1 mg
  • J0490Injection, belimumab, 10 mg
  • J0491Injection, anifrolumab-fnia, 1 mg
  • J0500Injection, dicyclomine hcl, up to 20 mg

Questions about J0463

What is HCPCS code J0463?

J0463 is a HCPCS Level II code for injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0463?

The CMS HCPCS file marks J0463 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J0463 paid under the physician fee schedule?

J0463 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026